title: Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy.
abstract: We investigated differences in the clinical findings between 30 patients with macrolide-resistant Mycoplasma pneumoniae pneumonia and 43 patients with macrolide-sensitive M. pneumoniae pneumonia in adolescents and adults. No differences in clinical presentation were observed between the two groups. Among patients with macrolide-resistant Mycoplasma pneumoniae pneumonia, treatment was more effective in the groups that received quinolones and minocycline than in the group that received macrolides (P = 0.0361 and P = 0.0237, respectively).
authors.affiliation: Department of Internal Medicine 1.
authors.forename: Naoyuki
authors.initials: N
authors.lastname: Miyashita
authors.forename: Hiroto
authors.initials: H
authors.lastname: Akaike
authors.forename: Hideto
authors.initials: H
authors.lastname: Teranishi
authors.forename: Kazunobu
authors.initials: K
authors.lastname: Ouchi
authors.forename: Niro
authors.initials: N
authors.lastname: Okimoto
mesh_terms: D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D005260:Female; D006801:Humans; D018942:Macrolides / Q000494:pharmacology*; D008297:Male; D008826:Microbial Sensitivity Tests; D008911:Minocycline / Q000494:pharmacology; D009177:Mycoplasma pneumoniae / Q000187:drug effects*; D015363:Quinolones / Q000494:pharmacology
chemical_list: D000900:Anti-Bacterial Agents; D018942:Macrolides; D015363:Quinolones; D008911:Minocycline
references.citation: Antimicrob Agents Chemother. 2004 Dec;48(12):4624-30
references.pmid: 15561835
references.citation: Respirology. 2012 Feb;17(2):354-62
references.pmid: 22077195
references.citation: Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72
references.pmid: 17278083
references.citation: Clin Infect Dis. 2010 Jul 15;51(2):189-94
references.pmid: 20540621
references.citation: J Infect Chemother. 2009 Dec;15(6):380-3
references.pmid: 20012728
references.citation: Microbiol Immunol. 2001;45(8):617-20
references.pmid: 11592636
references.citation: Eur J Clin Microbiol Infect Dis. 2011 Mar;30(3):439-46
references.pmid: 21061035
references.citation: Respirology. 2012 Oct;17(7):1073-9
references.pmid: 22563979
references.citation: J Med Microbiol. 2005 Apr;54(Pt 4):395-400
references.pmid: 15770027
references.citation: Respirology. 2007 Jan;12(1):104-10
references.pmid: 17207034
references.citation: Eur J Radiol. 2009 Dec;72(3):388-95
references.pmid: 18835120
references.citation: Antimicrob Agents Chemother. 2013 May;57(5):2252-8
references.pmid: 23459497
references.citation: Antimicrob Agents Chemother. 2003 Jan;47(1):161-5
references.pmid: 12499185
references.citation: BMC Infect Dis. 2012 May 31;12:126
references.pmid: 22650321
references.citation: BMC Med Imaging. 2009 Apr 29;9:7
references.pmid: 19400968
references.citation: Antimicrob Agents Chemother. 2006 Feb;50(2):709-12
references.pmid: 16436730
references.citation: Clin Infect Dis. 2012 Dec;55(12):1642-9
references.pmid: 22972867